255
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Polyurethane-based microparticles: Formulation and influence of processes variables on its characteristics

, , , &
Pages 154-169 | Received 31 May 2007, Accepted 13 Nov 2007, Published online: 08 Oct 2008

References

  • Arshady R. Albumin microspheres and microcapsules: methodology of manufacturing techniques. J Control Rel 1990; 14: 111–131
  • Batyrbekov EO, Rukhina LR, Zhubanov BA, Bekmukhamedova NF, Smailova GA. Drug delivery systems for tuberculosis treatment. Polym Int 1997; 43: 317–320
  • Boehm A-LR, Fessi H. Applications pharmaceutiques du potentil zeta–intérêt pour la caractérisation des vecteurs colloïdaux. J Pharm Belg 2000; 55: 40–48
  • Bogataj M, Vovk T, Kerec M, Dimnik A, Grabnar I, Mrhar A. The correlation between zeta potential and mucoadhesion strength on pig vesical mucosa. Biol Pharm Bull 2003; 26: 743–746
  • Bonferoni MC, Rossi S, Ferrari F, Stavik E, Pena-Romero A, Caramella C. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes 2000, AAPS Pharmscitech 1:article 15
  • Brett AMO, Brett CMA. Electroquímica: Princípios, Métodos e Aplicações. Livraria Almedina, Coimbra 1996; 71–74
  • Burgess DJ, Hickey AJ. Microsphere technology and applications. Encyclopedia of pharmaceutical technology, 2nd, J Swarbrick, JC Boylan. Marcel Dekker Inc, New York 2002; 1783–1794
  • Coelho JFJ, Carreira M, Popov AV, Gonçalves PMOF, Gil MH. Thermal and mechanical characterization of poly(vinyl chloride)-b-poly(butyl acrylate)-b-poly(vinyl chloride) obtained by single electron transfer—degenerative chain transfer living radical polymerization in water. Eur Polym J 2006; 42: 2313–2319
  • Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit® RS100. Int J Pharm 2006; 314: 72–82
  • Dillen K, Vandervoort J, Van den Mooter G, Verheyden L, Ludwig A. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharm 2004; 275: 171–187
  • Elwell MJ, Ryan AJ, Grünbauer HJM, Van Lieshout HC. An FT i.r. study of reaction kinetics and structure development in model flexible polyurethane foam systems. Polymer 1996; 37: 1353–1361
  • Govender S, Pillay V, Chetty DJ, Essack SY, Dangor CM, Govender T. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. Int J Pharm 2005; 306: 24–40
  • Guelcher SA, Gallagher KM, Didier JE, Klinedinst DB, Doctor JS, Goldstein AS, Wilkes GL, Beckman EJ, Hollinger JO. Synthesis of biocompatible segmented polyurethanes from aliphatic diisocyanates and diurea diol chain extenders. Acta Biomaterialia 2005; 1: 471–484
  • Heijkants RGJC, Schwab LW, van Calck RV, de Groot JH, Pennings AJ, Schouten AJ. Extruder synthesis of a new class of polyurethanes: polyacylurethanes based on poly(ϵ-caprolactone) oligomers. Polymer 2005; 46: 8981–8989
  • Jabbari E, Khakpour M. Morphology of and release behaviour from porous polyurethane microspheres. Biomaterials 2000; 21: 2073–2079
  • Jain SK, Chourasia MK, Masuriha R, Soni V, Jain A, Jain NK, Gupta Y. Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Del 2005; 12: 207–215
  • Jenkins MJ, Harrison KL. The effect of molecular weight on the crystallization kinetics of polycaprolactone. Polym Adv Tech 2006; 17: 474–478
  • Kawaguchi H. Functional polymer microspheres. Prog Polym Sci 2000; 25: 1171–1210
  • Kweon D-K, Cha D-S, Park H-J, Lim S-T. Starch-g-polycaprolactone copolymerization using diisocyanate intermediates and thermal characteristics of the copolymers. J App Polym Sci 2000; 78: 986–993
  • Kweon HY, Yoo MK, Park IK, Kim TH, Lee HC, Lee H-S, Oh J-S, Akaike T, Cho C-S. A novel degradable polycaprolactone networks for tissue engineering. Biomaterials 2003; 24: 801–808
  • La Gatta A, De Rosa A, Laurienzo P, Malinconico M, De Rosa M, Schiraldi C. A novel injectable poly(ϵ-caprolactone)/calcium sulfate system for bone regeneration: synthesis and characterization. Macromol Biosci 2005; 5: 1108–1117
  • Li LC, Tian Y. Zeta potential. Encyclopedia of pharmaceutical technology, 1st ed, J Swarbrick, JC Boylan. Marcel Dekker Inc, New York 1997; 429–458
  • Mahkam M, Sharifi-Sanjani N. Preparation of new biodegradable polyurethane as a therapeutic agent. Polym Degrad Stabil 2003; 80: 199–202
  • Mani R, Tang J, Bhattacharya M. Synthesis and characterization of starch-graft-polycaprolactone as compatibilizer for starch/polycaprlactone blends. Macromol Rapid Comm 1998; 19: 283–286
  • Melnig V, Apostu MO, Tura V, Ciobanu C. Optimization of polyurethane membranes: morphology and structure studies. J Memb Sci 2005; 267: 58–67
  • Patil GV. Biopolymer albumin for diagnosis and in drug delivery. Drug Dev Res 2003; 53: 219–247
  • Queiroz DP, Norberta de Pinho M. Structural characteristics and gas permeation properties of polydimethylsiloxane/poly (propylene oxide) urethane/urea bi-soft segment membranes. Polymer 2005; 46: 2346–2353
  • Santerre JP, Woodhouse K, Laroche G, Labow RS. Understanding the biodegradation of polyurethanes: From classical implants to tissue engineering maerials. Biomaterials 2005; 26: 7457–7470
  • Schaffazick SR, Guterres SS, Freitas LL, Pohlmann AR. Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos. Química Nova 2003; 26: 726–737
  • Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 2002; 21: 15–34
  • Vega E, Egea MA, Valls O, Espina M, García ML. Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration. J Pharm Sci 2006; 95: 2393–2405

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.